Protocol for Tongue Elastography and Ultrasound Markers
Tongue Shear-wave Elastography and Attenuation Ultrasound Markers in Healthy Subjects: a Protocol Study
1 other identifier
observational
55
1 country
1
Brief Summary
The purpose of this observational is to methodologically assess the standardisation and reliability of a protocol of ultrasound lingual markers, including tongue shear-wave elastography, attenuation indexes, and echo intensity in adult healthy subjects. The main goals are to create a standardized protocol and its intra- et inter-rater reliability, in order to gather some data in a non-pathological population. This protocol will be used in further studies in the context of tongue fat accumulation, such as in obstructive sleep apnea syndrome. Participants will be lying in supine position and after basic descriptive data collection (height, weight, neck circumference), submental ultrasound will be performed on them. This procedure is non-invasive, painless, safe (ultrasound does not involve ionising radiation) for the healthy participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 28, 2025
CompletedFirst Posted
Study publicly available on registry
June 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 5, 2026
December 1, 2025
7 months
May 28, 2025
January 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Tongue stiffness (ultrasound)
Tongue stiffness (in kPa), measured with shear-wave elastography (ultrasound submental approach)
Day 1
Tongue Echo Intensity (ultrasound)
Tongue Echo Intensity, expressed as the mean value of pixels in a 0-255 gray scale (ultrasound submental approach)
Day 1
Tongue Tissue Attenuation Imaging (ultrasound)
Tongue Tissue Attenuation Imaging, measured with ultrasound submental approach, reflecting the quantitative measurement of US attenuation in tissue in dB/cm/MHz
Day 1
Tongue thickness (ultrasound)
Tongue thickness (in cm, measured via ultrasound submental approach), reflects its size, representing the vertical distance between its most superior surface point to its most inferior
Day 1
Secondary Outcomes (5)
Age
Day 1
Weight
Day 1
Height
Day 1
Neck circumference
Day 1
Body Mass Index (BMI)
Day 1
Other Outcomes (2)
Berlin Sleep Questionnaire
Day 1
Stop-Bang Questionnaire
Day 1
Study Arms (1)
Healthy adult subjects
Healthy subjects (aged 18-45), male and female. All subjects will give their informed consent. Consequently, exclusion criteria will include any orthopaedic, traumatological or rheumatic pathology of the cervico-cephalic extremities, as well as any metabolic (diabetes, metabolic syndrome, etc.) or cardiovascular pathology. In particular, subjects must not suffer from sleep disorders or OSA, as identified by the Berlin Sleep Questionnaire and Stop-BANG questionnaire. Subjects will be asked not to consume alcohol or drugs 48 hours before the experiment.
Interventions
Descriptive and anthropometric data will be recorded for each participant, including age, sex, weight (kg), height (m), neck circumferences (cm). Body mass index (expressed in kg/m2) will be calculated. Submental ultrasound (US) images of the tongue will be performed on a patient lying supine, using a 5-15 MHz convex transducer. The parameters will be identical for all subjects and set at a depth of 9 cm, a focus of 4 cm and a gain of 45%. Each measurement will be taken thrice by a trained operator; the mean and standard deviation being used for analysis.
Eligibility Criteria
Healthy subjects (aged 18-45), male and female, recruited from physiotherapy students at ISEK-HE2B and health students at VUB (Brussels Health Campus site in 1090 Jette) and their relatives.
You may qualify if:
- Healthy adults aged 18-45 years
- Able to understand and provide informed consent
You may not qualify if:
- Any orthopaedic, traumatic, or rheumatic conditions affecting the head or neck
- Presence of metabolic disorders (e.g., diabetes, metabolic syndrome)
- Presence of cardiovascular conditions
- Diagnosed sleep disorders or known sleep apnea syndrome, as evaluated by the Stop-Bang and Berlin questionnaires
- Consumption of alcohol or drugs within 48 hours prior to the experiment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Isek He2B
Brussels, 1160, Belgium
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Steven Provyn, PhD
HE2B & VUB
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, MSc PT Drs
Study Record Dates
First Submitted
May 28, 2025
First Posted
June 17, 2025
Study Start
September 5, 2024
Primary Completion
April 1, 2025
Study Completion
December 1, 2025
Last Updated
January 5, 2026
Record last verified: 2025-12